Literature DB >> 1269103

The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.

T K Keeton, W A Pettinger, W B Campbell.   

Abstract

Circulating angiotensin II is said to inhibit renin release by a direct, intrarenal action. This effect of angiotensin was studied indirectly using the selective angiotensin II antagonist saralasin (1Sar-8-Ala-angiotensin II) in conscious normal, sodium-depleted, and sodium-loaded rats. Saralasin caused a dose-related increase in plasma renin concentration (PRC) in normal and sodium-depleted rats, but had no effect on PRC in sodium-loaded animals. However, saralasin was 300 times more active in sodium-depleted rats than in normal rats. Saralasin caused hypotension and tachycardia in sodium-depleted rats, but not in normals. Propranolol inhibited saralasin-induced renin release by 99% in normal rats and by 75% in sodium-depleted rats but not alter the hypotensive effect of saralasin in the latter. Saralasin potentiated phentolamine-induced renin release, hypotension, and tachycardia in normal rats, and this potentiated renin release was blocked by propranolol. We conclude that a portion of saralasin-elicited renin release in sodium-depleted rats is mediated by hypotensive activation of the carotid baroreceptor reflex which increases sympathetic nervous activity in the kidney. However, in sodium-depleted rats saralasin induced a 42-fold increase in PRC, whereas an equipotent hypotensive dose of the vasodilator hydralazine caused only a 3.5-fold increase in PRC. Thus, we find that saralasin appears to have a selective effect on renin release over and above its hypotensive effect, which suggests an angiotensin-mediated, feedback mechanism inhibitory to renin release. Thus, we have come to the conclusion that for part of saralasin-induced renin release appears to be caused by disinhibition of angiotensin suppression of renin secretion. This "short-loop" feed-back mechanism is closely associated with intrarenal beta-adrenergic receptors, since propranolol impaired saralasin-induced renin release under all circumstances in our experiments.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269103     DOI: 10.1161/01.res.38.6.531

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  4 in total

1.  The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.

Authors:  D Cambridge; M V Whiting; L J Butterfield; G Allan
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

2.  [Critical analysis of the saralasintest in the diagnosis of hypertension (author's transl)].

Authors:  A Röckel; H Wernze; B Sabel; A Heidland
Journal:  Klin Wochenschr       Date:  1977-07-01

3.  Intracranial volume receptors: possible role on ADH homeostatic control.

Authors:  A Satta; D Palomba; M P Demontis; M V Varoni; R Faedda; A Ginanni; V Anania
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

4.  Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.

Authors:  C S Liang; H Gavras; W B Hood
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.